DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy. Read more about DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy.
Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States. Read more about Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States.
Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia. Read more about Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia.
Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. Read more about Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study.
Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters. Read more about Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters.
Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America. Read more about Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America.
Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B. Read more about Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B.
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. Read more about Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B.
Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. Read more about Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.
Determination of hepatitis B phenotype using biochemical and serological markers. Read more about Determination of hepatitis B phenotype using biochemical and serological markers.
